| Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier Y Gilgun-Sherki, E Melamed, D Offen Neuropharmacology 40 (8), 959-975, 2001 | 1099 | 2001 |
| The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy Y Gilgun-Sherki, E Melamed, D Offen Journal of neurology 251, 261-268, 2004 | 812 | 2004 |
| Antioxidant therapy in acute central nervous system injury: current state Y Gilgun-Sherki, Z Rosenbaum, E Melamed, D Offen Pharmacological reviews 54 (2), 271-284, 2002 | 772 | 2002 |
| Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease M Vila, V Jackson-Lewis, S Vukosavic, R Djaldetti, G Liberatore, D Offen, ... Proceedings of the National Academy of Sciences 98 (5), 2837-2842, 2001 | 445 | 2001 |
| The “dying-back” phenomenon of motor neurons in ALS M Dadon-Nachum, E Melamed, D Offen Journal of molecular neuroscience 43, 470-477, 2011 | 417 | 2011 |
| In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles O Betzer, N Perets, A Angel, M Motiei, T Sadan, G Yadid, D Offen, ... ACS nano 11 (11), 10883-10893, 2017 | 351 | 2017 |
| Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice E Hochhauser, S Kivity, D Offen, N Maulik, H Otani, Y Barhum, H Pannet, ... American Journal of Physiology-Heart and Circulatory Physiology 284 (6 …, 2003 | 333 | 2003 |
| Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a … P Petrou, Y Gothelf, Z Argov, M Gotkine, YS Levy, I Kassis, ... JAMA neurology 73 (3), 337-344, 2016 | 322 | 2016 |
| Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease D Offen, I Ziv, H Sternin, E Melamed, A Hochman Experimental neurology 141 (1), 32-39, 1996 | 319 | 1996 |
| Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury S Guo, N Perets, O Betzer, S Ben-Shaul, A Sheinin, I Michaelevski, ... ACS nano 13 (9), 10015-10028, 2019 | 316 | 2019 |
| Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders N Perets, O Betzer, R Shapira, S Brenstein, A Angel, T Sadan, U Ashery, ... Nano letters 19 (6), 3422-3431, 2019 | 315 | 2019 |
| Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons—a possible novel pathogenetic mechanism in Parkinson's disease I Ziv, E Melamed, N Nardi, D Luria, A Achiron, D Offen, A Barzilai Neuroscience letters 170 (1), 136-140, 1994 | 311 | 1994 |
| Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity D Offen, PM Beart, NS Cheung, CJ Pascoe, A Hochman, S Gorodin, ... Proceedings of the National Academy of Sciences 95 (10), 5789-5794, 1998 | 286 | 1998 |
| Apoptosis and Parkinson's disease N Lev, E Melamed, D Offen Progress in Neuro-Psychopharmacology and Biological Psychiatry 27 (2), 245-250, 2003 | 254 | 2003 |
| Human mesenchymal stem cells express neural genes, suggesting a neural predisposition NR Blondheim, YS Levy, T Ben-Zur, A Burshtein, T Cherlow, I Kan, ... Stem cells and development 15 (2), 141-164, 2006 | 223 | 2006 |
| Concise review: mesenchymal stem cells in neurodegenerative diseases R Volkman, D Offen Stem cells 35 (8), 1867-1880, 2017 | 211 | 2017 |
| Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents MA Hellmann, H Panet, Y Barhum, E Melamed, D Offen Neuroscience letters 395 (2), 124-128, 2006 | 188 | 2006 |
| Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease D Offen, Y Sherki, E Melamed, M Fridkin, DE Brenneman, I Gozes Brain research 854 (1-2), 257-262, 2000 | 183 | 2000 |
| Protective effects of neurotrophic factor–secreting cells in a 6-OHDA rat model of Parkinson disease O Sadan, M Bahat-Stromza, Y Barhum, YS Levy, A Pisnevsky, H Peretz, ... Stem cells and development 18 (8), 1179-1190, 2009 | 175 | 2009 |
| Enhanced Oxidative Stress and Altered Antioxidants in Brains of Bcl‐2‐Deficient Mice A Hochman, H Sternin, S Gorodin, S Korsmeyer, I Ziv, E Melamed, ... Journal of neurochemistry 71 (2), 741-748, 1998 | 174 | 1998 |
Ran BarzilayUniversity of Pennsylvania and Children's Hospital of Philadelphia在 email.chop.edu 的电子邮件经过验证
